Authors:
Bjugstad, KB
Zawada, WM
Goodman, SI
Freed, CR
Citation: Kb. Bjugstad et al., IGF-1 and bFGF reduce glutaric acid and 3-hydroxyglutaric acid toxicity instriatal cultures, J INH MET D, 24(6), 2001, pp. 631-647
Citation: Kb. Bjugstad et al., CPI-1189 prevents apoptosis and reduces glial fibrillary acidic protein immunostaining in a TNF-alpha infusion model for AIDS dementia complex, J NEUROVIRO, 6(6), 2000, pp. 478-491
Citation: Kb. Bjugstad et al., Age at symptom onset predicts severity of motor impairment and clinical outcome of glutaric acidemia type 1, J PEDIAT, 137(5), 2000, pp. 681-686
Citation: Kb. Bjugstad et Gw. Arendash, An intracerebral tumor necrosis factor-alpha infusion model for inflammation in Alzheimer's disease, CONT NEUROS, 2000, pp. 93-112
Authors:
Linert, W
Bridge, MH
Huber, M
Bjugstad, KB
Grossman, S
Arendash, GW
Citation: W. Linert et al., In vitro and in vivo studies investigating possible antioxidant actions ofnicotine: relevance to Parkinson's and Alzheimer's diseases, BBA-MOL BAS, 1454(2), 1999, pp. 143-152
Authors:
Arendash, GW
Su, GC
Crawford, FC
Bjugstad, KB
Mullan, M
Citation: Gw. Arendash et al., Intravascular beta-amyloid infusion increases blood pressure: implicationsfor a vasoactive role of beta-amyloid in the pathogenesis of Alzheimer's disease, NEUROSCI L, 268(1), 1999, pp. 17-20
Authors:
Socci, DJ
Bjugstad, KB
Jones, HC
Pattisapu, JV
Arendash, GW
Citation: Dj. Socci et al., Evidence that oxidative stress is associated with the pathophysiology of inherited hydrocephalus in the H-Tx rat model, EXP NEUROL, 155(1), 1999, pp. 109-117
Authors:
Su, GC
Arendash, GW
Kalaria, RN
Bjugstad, KB
Mullan, M
Citation: Gc. Su et al., Intravascular infusions of soluble beta-amyloid compromise the blood-brainbarrier, activate CNS glial cells and induce peripheral hemorrhage, BRAIN RES, 818(1), 1999, pp. 105-117